Evaluation of several tests in screening for chloroquine maculopathy
Authors:
- 1 November 1989
- journal article
- clinical trial
- Published by Springer Nature in Eye
- Vol. 3 (6) , 777-782
Abstract
Patients receiving antimalarial therapy, specifically hydroxychloroquine, for different periods were evaluated using contrast sensitivity test (CST) and results were compared with those of electro-retinography (EOG), and pattern visual evoked potential (PVEP), and a matching age control group. The results indicated CST to be most sensitive of the evaluated techniques particularly in patients under 40 years old. In 44.4% of the cases CST revealed macular dysfunction of which the other two methods of examination were not capable. Our findings suggest the CST is a reliable and practical method which could be used as an additional screening test for chloroquine maculopathy.Keywords
This publication has 14 references indexed in Scilit:
- Chloroquine RetinopathyOphthalmology, 1985
- Contrast SensitivityArchives of Ophthalmology (1950), 1984
- The Use of Amsler Grids in Early Chloroquin RetinopathyOphthalmology, 1984
- THE EOG IN RHEUMATOID ARTHRITISActa Ophthalmologica, 1983
- An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of todayAnnals of the Rheumatic Diseases, 1982
- Abnormalities of Central Contrast Sensitivity in GlaucomaAmerican Journal of Ophthalmology, 1979
- Chloroquine RetinopathyArchives of Ophthalmology (1950), 1966
- The EOG in Chloroquine and Other RetinopathiesArchives of Ophthalmology (1950), 1963
- Chloroquine RetinopathyArchives of Ophthalmology (1950), 1963
- ANTICIPATION OF CHLOROQUINE RETINOPATHYThe Lancet, 1962